Seoul, South Korea

Sung-Sick Woo

This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Unigen Corporation. Active years: 2011-2017.

USPTO Granted Patents = 3 

% Patents Active = 33.3

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 79(Granted Patents)


Company Filing History:


Years Active: 2011-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Sung-Sick Woo

Introduction

Sung-Sick Woo is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of skin and metabolic disorders. With a total of three patents to his name, his work focuses on natural compositions that address various health issues.

Latest Patents

One of his latest patents is a composition for treating atopic dermatitis, which comprises extracts of bamboo and scutellaria. This invention relates to a natural ingredient that can control immune responses by inhibiting the release of histamine and leukotriene. It has been proven safe and effective in clinical trials for the treatment and prevention of atopic dermatitis. Another significant patent is a pharmaceutical composition for preventing and treating diabetes or glucose control abnormalities, which includes ginsenosides Rg3, Rg5, and Rk1. This composition can effectively prevent or treat diabetes and related complications.

Career Highlights

Sung-Sick Woo is currently associated with Unigen Corporation, where he continues to innovate in the field of natural health products. His work has garnered attention for its focus on utilizing plant extracts to create effective treatments.

Collaborations

He collaborates with notable colleagues, including Dong-Seon Kim and Seon-Gil Do, who contribute to his research and development efforts.

Conclusion

Sung-Sick Woo's innovative work in developing natural compositions for treating various health conditions highlights his commitment to improving patient care through scientific advancements. His contributions are paving the way for future research in the field of pharmaceuticals.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…